Gavi is proud to announce that INFUSE 2024 is actively seeking innovative solutions uniquely positioned to enhance health systems, enabling them to effectively manage resilient and climate-adaptive responses to climate threats.
Challenge
The climate crisis stands as the foremost threat to human health. Climate change exacerbates existing health challenges and introduces new ones, including increased vulnerability to diseases sensitive to climate conditions – such as malaria – and the likelihood of more frequent and severe disease outbreaks due to extreme weather. Immunisation has been identified as a critical adaptation strategy to reduce vulnerability to climate change.
Opportunity
Gavi is leveraging its portfolio of vaccines, including some against deadly climate-sensitive diseases such as malaria, typhoid, yellow fever and cholera, as well as its portfolio of scaling innovations in last-mile delivery, data and demand generation. To further expand this toolbox, INFUSE is actively seeking groundbreaking solutions uniquely positioned to modernise health systems.
INFUSE 2024 will surface innovations that aim to develop low-carbon and sustainable health care systems – enhancing the skills of the health care workforce to navigate immunisation challenges, and to anticipate and respond to disruptions.
Read more and Apply